Combination of angiopoietin-1 and vascular endothelial growth factor gene therapy enhances arteriogenesis in the ischemic myocardium

Biochemical and Biophysical Research Communications

Volumn 310, Issue 3, 2003, Pages 1002-1009

  Siddiqui, A J ^a   Blomberg, P ^b   Wardell E ^a   Hellgren, I ^a   Eskandarpour, M ^b   Islam, K B ^b   Sylven C ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Clinical Research Center   (Sweden)

Author keywords

Angiogenesis; Angiopoietin 1; Arteriogenesis; Gene therapy; Myocardial ischemia; Vascular endothelial growth factor

Indexed keywords

ANGIOPOIETIN 1; SODIUM CHLORIDE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE THERAPY; GENE TRANSFER; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HYPOTHESIS; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL;

EID: 0141645244     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.09.111     Document Type: Article

References (23)

1. Banai S., Shweiki D., Pinson A., Chandra M., Lazarovici G., Keshet E. Upregulation of vascular endothelial growth factor expression induced by myocardial ischemia: implications of coronary angiogenesis. Cardiovasc. Resc. 28:1994;1176-1179.
2. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1:1995;27-31.
3. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., Holash J. Vascular-specific growth factors and blood vessel formation. Nature. 407:2000;242-248.
4. Suri C., McClain J., Thurston G., McDonald D.M., Zhou H., Oldmixon E.H., Sato T.N., Yancopoulos G.D. Increased vascularization in mice over-expressing angiopoietin-1. Science. 282:1998;468-471.
5. Suri C., Jones P.F., Patan S., Bartunkova S., Maisonpierre P.C., Davis S., Sato T.N., Yancopoulos G.D. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell. 87:1996;1171-1180.
6. Chae J.K., Kim I., Lim S.T., Chung M.J., Kim W.H., Kim H.G., Ko J.K., Koh G.Y. Co-administration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization. Arterioscler. Throm. Vasc. Biol. 20:2000;2573-2585.
7. Asahara T., Chen D., Takahashi T., Fujikawa K., Kearney M., Magner M., Yancopoulos G.D., Isner J.M. Tie2 receptor ligands, angiopoietin-1 and angiopoeitin-2, modulate VEGF-induced postnatal neovascularization. Circ. Res. 83:1998;233-240.
8. Jones M.K., Kawanaka H., Baata D., Szabó I.L., Tsugawa K., Pai R., Koh G.Y., Kim I., Sarfeh I.J., Tarnawski A.S. Gene therapy for gastric ulcers with single local injection of naked DNA encoding VEGF and Angiopoietin-1. Gastroenterology. 121:2001;1040-1047.
9. Arsic N., Zentilin L., Zacchigna S., Santoro D., Stanta G., Salvi A., Sinagra G., Giacca M. Induction of functional neovascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors. Mol. Therapy. 7:2003;450-459.
10. Hattori K., Dias S., Heissig B., Hackett N.R., Lyden D., Tateno M., Hicklin D.J., Zhu Z., Witte L., Crystal R.G., Moore A.S.M., Rafii S. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal haematopoiesis by recruitment of vasculogenic and haematopoietic stem cells. J. Exp. Med. 193:2001;1005-1014.
11. Tsurumi Y., Takeshita S., Chen D., Kearney M., Rossow S.T., Passeri J., Horowitz J.R., Symes J.F., Isner J.M. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation. 94:1996;3281-3290.
12. Blomberg P., Eskandarpour M., Xia S., Sylvén C., Islam K.B. Electroporation in combination with a plasmid vector containing SV40 enhancer elements results in increased and persistent gene expression in mouse muscle. Biochem. Biophys. Res. Commun. 298(4):2002;505-510.
13. Kellar R.S., Landeen L.K., Shepherd B.R., Naughton G.K., Ratcliffe A., Williams S.K. Scaffold-based three-dimensional human fibroblast culture provides a structural matrix that supports angiogenesis in infarcted heart tissue. Circulation. 104:2001;2063-2068.
14. Xia Q.G., Chung O., Spitznagel H., Illner S., Jänichen G., Rossius B., Gohlke P., Unger T. Significance of timing of angiotensin AT1 receptor blockade in rats with myocardial infarction-induced heart failure. Cardiovasc. Res. 49:2001;110-117.
15. Mulder P., Devaux B., Richard V., Henry J.P., Wimart M.C., Thibout E., Mace B., Thuillez C. Early versus delayed angiotensin-converting enzyme inhibition in experimental chronic heart failure. Effects on surival, hemodynamics and cardiovascular remodelling. Circulation. 95:1997;1314-1319.
16. Gamble J.R., Drew J., Trezise L., Underwood A., Parson M., Kasminkas L., Rudge J., George D.Y., Vadas M.A. Angiopoietin-1 is anti permeability and anti-inflammatory agent in vitro and targets cell junctions. Circ. Res. 87:2000;603-607.
17. Dvorak H.F. Tumors: wounds that do not heal. Similarity between tumour stroma generation and wound healing. N. Eng. J. Med. 315:1986;1650-1658.
18. Ishida A., Murray J., Saito Y., Kanthou C., Benzakour O., Shibuya M., Wijelath E.S. Expression of vascular endothelial growth factor receptors in smooth muscle cells. J. Cell Physiol. 188:2001;359-368.
19. Dor Y., Djonov V., Abramovitch R., Itin A., Fishman G.I., Carmeliet P., Goelman G., Keshet E. Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy. EMBO J. 21:2002;1939-1947.
20. Ray P.S., Estrada-Hernandez T., Sasaki H., Zhu L., Maulik N. Early effects of hypoxia/reoxygenation on VEGF, ang-1, ang-2 and their receptors in the rat myocardium: implications for myocardial angiogenesis. Mol. Cell Biochem. 213(1-2):2000;145-153.
21. Corpechot C., Barbu V., Wendum D., Kinnman N., Rey C., Poupon R., Housset C., Rosmorduc O. Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis. Hepatology. 35(5):2002;1010-1021.
22. Rissanen T.T., Vajanto I., Hiltunen M.O., Rutanen J., Kettunen M.I., Niemi M., Leppanen P., Turunen M.P., Markkanen J.E., Arve K., Alhava E., Kauppinen R.A., Yla-Herttuala S. Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration. Am. J. Pathol. 160(4):2002;1393-1403.
23. Ray P.S., Sasaki H., Estrada-Hernandez T., Zu L., Maulik N. Effects of hypoxia/reoxygenation on angiogenic factors and their tyrosine kinase receptors in the rat myocardium. Antioxid. Redox Signal. 3:2001;89-102.